The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer (HGCSG1503): Analysis of cases of prior regorafenib.
 
Tomoyuki Ohta
No Relationships to Disclose
Low Count of CD4+ T Lymphocytes as a Predictor of Varicella-Zoster Virus (VZV) Reactivation Following Autologous Peripheral Blood STEM Cell Transplantation (Auto-PBSCT) in Breast Cancer Patients.
 
Atsushi Ishiguro
No Relationships to Disclose
 
Satoshi Yuki
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda
 
Hiroshi Nakatsumi
No Relationships to Disclose
 
Takuro Saiki
No Relationships to Disclose
 
Yasushi Tsuji
No Relationships to Disclose
 
Kazuteru Hatanaka
No Relationships to Disclose
 
Hiroki Yoshita
No Relationships to Disclose
 
Shinya Minami
No Relationships to Disclose
 
Kazunori Eto
No Relationships to Disclose
 
Junta Nakajima
No Relationships to Disclose
 
Michio Nakamura
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo
Research Funding - Astellas Pharma (Inst); Takeda (Inst); Zeria Pharmaceutical (Inst)
 
Kazuhiro Suzuki
No Relationships to Disclose
 
Masahiko Koike
No Relationships to Disclose
 
Kanji Kato
No Relationships to Disclose
 
Miki Tateyama
No Relationships to Disclose
 
Chiaki Asada
No Relationships to Disclose
 
Mari Sekiguchi
No Relationships to Disclose
 
Yuh Sakata
Honoraria - Chugai Pharma; Daiichi Sankyo; Otsuka; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
 
Yoshito Komatsu
Honoraria - Bayer; Novartis; Pfizer
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Bayer; Chugai Pharma; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical